Main market
Access this stock data via API
Subscribe
Towa Pharmaceutical Co., Ltd.
0
0
0%

Financials

Income statement

Fiscal date 2025 2024 2023 2022
Total reported revenue 259.6B 227.9B 208.9B 165.6B
Cost of revenue 164.9B 146.6B 136.1B 95.4B
Gross profit 94.7B 81.4B 72.7B 70.2B
Operating expense
Research & development
Selling general and admin
Other operating expenses
Operating income 23.2B 17.6B 5.5B 19.2B
Non operating interest income
Income 221M 97M 17M 8M
Expense 1.6B 947M 635M 230M
Other income expense
Pretax income 26.3B 24.5B 4.6B 22.2B
Tax provision 7.3B 8.3B 2.4B 6.3B
Net income 19.0B 16.2B 2.2B 15.9B
Basic EPS 385.7 328.6 44.7 323.4
Diluted EPS 385.7 328.6 44.7 316.2
Basic average shares 49.2M 49.2M 49.2M 49.2M
Diluted average shares 49.2M 49.2M 49.2M 49.2M
EBITDA 46.6B 37.8B 27.0B 31.7B
Net income from continuing op. 26.3B 24.5B 4.6B 22.2B
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 33 minutes

12:56
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 15:30
All times are displayed in the Asia/Tokyo timezone (JST, UTC+09:00).